The Latest Cardiac and Vascular News
IRVINE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported financial results for its second quarter ended June 30, 2021. Second Quarter Revenue […]
– Revenues Increased 41% Year-over-Year to $12.6 Million – – U.S. WatchPATTM Revenues Increased 53% Year-over-Year to $10.1 Million – – Raised Full Year 2021 Revenue Guidance to a Range of $53 Million to $54 Million – – Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT […]
– Company established with world-class research from leading academia and industry leaders– Lead program targets a novel kinase involved in cellular stress response – Experienced and proven team advancing therapies for Long QT Syndrome and resistant cancers LAVAL, QC, Aug. 10, 2021 /PRNewswire/ – LQT Therapeutics, Inc. (LQTT) a pharmaceutical company pioneering the […]
Presentation showcases immediate, complete, and lasting peripheral artery occlusion achieved in a study with company’s new embolization technology PRAIRIE VILLAGE, Kan., Aug. 10, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the presentation of data highlighting the […]
EDEN PRAIRIE, Minn., Aug. 10, 2021 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the second quarter ended June 30, 2021, which included the following highlights: Reported record quarterly revenue of $2.5 million, a 35 percent increase compared to the prior year period Realized strong sequential […]
ST. LOUIS, Aug. 10, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the second quarter ended June 30, 2021. “Renewed global adoption of robotic systems continues to drive robust double digit revenue growth for Stereotaxis,” […]
Launched subcutaneous delivery of Treprostinil Injection, doubling market opportunity Resubmitted New Drug Application (NDA) for LIQ861 (treprostinil) inhalation powder Improved balance sheet with private placement and increased financial discipline Company to host webcast and conference call today at 8:30 a.m. ET MORRISVILLE, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation […]
Revenue rebound, strong procedural recovery Management to host investor conference call today, August 10, 2021, at 8:30am ET TEL AVIV, Israel, Aug. 10, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid […]
CARY, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) — Chiesi USA (key-ay-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced the publication of a cost-consequence analysis of KENGREAL® (cangrelor) in patients receiving percutaneous coronary intervention (PCI) in the online edition of the American Journal of Cardiovascular Drugs. KENGREAL […]
SILVER SPRING, Md., Aug. 09, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three and six months ended June 30, 2021. Recent […]
